Opinion
A Future Beyond Animal Testing: Why ORIVA Matters and How Computational Models Bridge the Gap
Animal testing is costly, slow, and poorly predictive. ORIVA offers a human-relevant alternative with the potential to change that.
A conditional generative adversarial network architecture was implemented to generate synthetic data. Use cases were myelodysplastic syndromes (MDS) and AML: 7,133 patients were included. A fully ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback